2Seventy Bio

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range $1.53-$11.29
Market Cap $206.1M
Shares Short 6M

Financials

See more
Revenue (12 Mos) $71.2M
Revenue Growth (YoY) -70.1%
Gross Profit (12 Mos) -$183.4M
Diluted EPS -$4.35

News

See more

Yahoo Finance • 5 months ago

Bristol Myers Squibb and 2seventy bio Share Update on U.S. FDA Oncologic Drugs Advisory Committee Meeting for Abecma in Triple-Class Exposed Multiple Myeloma Based on KarMMa-3 Study

Yahoo Finance • 7 months ago

Abecma Delivers Sustained Progression-Free Survival Versus Standard Regimens in Earlier Lines of Therapy for Relapsed and Refractory Multiple Myeloma Based on Longer-Term Follow-up from KarMMa-3

Yahoo Finance • 10 months ago

10 Stocks That Are About To Explode

Yahoo Finance • last year

Regulatory Applications Accepted Across Three Regions Globally for Abecma for Earlier Use in Adults with Triple-Class Exposed Relapsed and/or Refractory Multiple Myeloma

About

Address 60 Binney Street, Cambridge, MA, United States, 02142
Sector Healthcare
Industry Biotechnology
Full-Time Employees 274